Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.66 USD | +3.74% | +19.57% | -24.83% |
May. 13 | JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating | MT |
May. 10 | Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |